Table 1.
The prevalence of foot lesions (hyperkeratosis, fissures, nodular lesions, and papillomatous growths) and mean (±SD) foot score for each lesion type at Time Points A (6 May 2021), B (16 April 2022), and C (9 November 2022).
| Prevalence | |||
|---|---|---|---|
| A | B | C | |
| Foot Lesions (overall) | 99.0% (96/97) | 100% (97/97) | 59.8% (58/97) |
| - Hyperkeratosis | 99.0% (96/97) | 93.8% (91/97) | 53.6% (52/97) |
| - Fissures | 58.8% (57/97) | 70.1% (68/97) | 12.4% (12/97) |
| - Nodular Lesions | 4.1% (4/97) | 0% (0/97) | 1.0% (1/97) |
| - Papillomatous Growths | 89.7% (87/97) | 100% (97/97) | 22.7% (22/97) |
| Mean (±SD) Foot Score | |||
| A | B | C | |
| Foot Lesions (overall) | 8.60 (3.83) | 13.75 (6.81) | 1.78 (2.54) |
| - Hyperkeratosis | 3.40 (1.93) | 2.73 (1.78) | 1.05 (1.39) |
| - Fissures | 1.06 (1.20) | 2.24 (2.61) | 0.19 (0.63) |
| - Nodular Lesions | 0.05 (0.27) | 0 | 0.02 (0.20) |
| - Papillomatous Growths | 4.08 (2.84) | 8.68 (4.86) | 0.53 (1.40) |